Meeting
2020 ASCO Virtual Scientific Program
Tumor response and growth rate of nivolumab treatment in advanced gastric cancer: Real-world data from a large observational/translational study, JACCRO GC-08 (deliver trial).
Authors
Ryohei Kawabata
Department of Surgery, Osaka Prefectual General Medical Center, Osaka, Japan
Ryohei Kawabata , Yasuhiro Sakamoto , Eisuke Inoue , Atsushi Ishiguro , Yusuke Akamaru , Yosuke Kito , Masazumi Takahashi , Jin Matsuyama , Hiroshi Yabusaki , Akitaka Makiyama , Takahisa Suzuki , Masahiro Tsuda , Hisateru Yasui , Hisato Kawakami , Ryo Matoba , Kei Muro , Takako Eguchi Nakajima , Wataru Ichikawa , Masashi Fujii , Yu Sunakawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
UMIN000030850
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4527)
DOI
10.1200/JCO.2020.38.15_suppl.4527
Abstract #
4527
Poster Bd #
135
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Survival analysis by tumor response from real-world data in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08).
First Author: Yosuke Kito
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.
First Author: Mai Utsumi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of time-of-day on nivolumab monotherapy infusion in patients with metastatic gastric cancer.
First Author: Yasunobu Ishizuka
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla